261 related articles for article (PubMed ID: 23027640)
1. A comparative evaluation of NB30, NB54 and PTC124 in translational read-through efficacy for treatment of an USH1C nonsense mutation.
Goldmann T; Overlack N; Möller F; Belakhov V; van Wyk M; Baasov T; Wolfrum U; Nagel-Wolfrum K
EMBO Mol Med; 2012 Nov; 4(11):1186-99. PubMed ID: 23027640
[TBL] [Abstract][Full Text] [Related]
2. Beneficial read-through of a USH1C nonsense mutation by designed aminoglycoside NB30 in the retina.
Goldmann T; Rebibo-Sabbah A; Overlack N; Nudelman I; Belakhov V; Baasov T; Ben-Yosef T; Wolfrum U; Nagel-Wolfrum K
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6671-80. PubMed ID: 20671281
[TBL] [Abstract][Full Text] [Related]
3. Translational read-through as an alternative approach for ocular gene therapy of retinal dystrophies caused by in-frame nonsense mutations.
Nagel-Wolfrum K; Möller F; Penner I; Wolfrum U
Vis Neurosci; 2014 Sep; 31(4-5):309-16. PubMed ID: 24912600
[TBL] [Abstract][Full Text] [Related]
4. PTC124-mediated translational readthrough of a nonsense mutation causing Usher syndrome type 1C.
Goldmann T; Overlack N; Wolfrum U; Nagel-Wolfrum K
Hum Gene Ther; 2011 May; 22(5):537-47. PubMed ID: 21235327
[TBL] [Abstract][Full Text] [Related]
5. Ataluren and aminoglycosides stimulate read-through of nonsense codons by orthogonal mechanisms.
Ng MY; Li H; Ghelfi MD; Goldman YE; Cooperman BS
Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33414181
[TBL] [Abstract][Full Text] [Related]
6. Ataluren for the Treatment of Usher Syndrome 2A Caused by Nonsense Mutations.
Samanta A; Stingl K; Kohl S; Ries J; Linnert J; Nagel-Wolfrum K
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31842393
[TBL] [Abstract][Full Text] [Related]
7. Functional rescue of REP1 following treatment with PTC124 and novel derivative PTC-414 in human choroideremia fibroblasts and the nonsense-mediated zebrafish model.
Moosajee M; Tracey-White D; Smart M; Weetall M; Torriano S; Kalatzis V; da Cruz L; Coffey P; Webster AR; Welch E
Hum Mol Genet; 2016 Aug; 25(16):3416-3431. PubMed ID: 27329764
[TBL] [Abstract][Full Text] [Related]
8. Aminoglycosides, but not PTC124 (Ataluren), rescue nonsense mutations in the leptin receptor and in luciferase reporter genes.
Bolze F; Mocek S; Zimmermann A; Klingenspor M
Sci Rep; 2017 Apr; 7(1):1020. PubMed ID: 28432296
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo treatment with a novel synthetic aminoglycoside NB54 in primary fibroblasts from Rett syndrome patients suppresses MECP2 nonsense mutations.
Vecsler M; Ben Zeev B; Nudelman I; Anikster Y; Simon AJ; Amariglio N; Rechavi G; Baasov T; Gak E
PLoS One; 2011; 6(6):e20733. PubMed ID: 21695138
[TBL] [Abstract][Full Text] [Related]
10. Harmonin in the murine retina and the retinal phenotypes of Ush1c-mutant mice and human USH1C.
Williams DS; Aleman TS; Lillo C; Lopes VS; Hughes LC; Stone EM; Jacobson SG
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3881-9. PubMed ID: 19324851
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of premature stop codon readthrough in the CFTR gene by Ataluren (PTC124) derivatives.
Pibiri I; Lentini L; Melfi R; Gallucci G; Pace A; Spinello A; Barone G; Di Leonardo A
Eur J Med Chem; 2015 Aug; 101():236-44. PubMed ID: 26142488
[TBL] [Abstract][Full Text] [Related]
12. The Usher syndrome 1C protein harmonin regulates canonical Wnt signaling.
Schäfer J; Wenck N; Janik K; Linnert J; Stingl K; Kohl S; Nagel-Wolfrum K; Wolfrum U
Front Cell Dev Biol; 2023; 11():1130058. PubMed ID: 36846582
[TBL] [Abstract][Full Text] [Related]
13. In vitro read-through of phenylalanine hydroxylase (PAH) nonsense mutations using aminoglycosides: a potential therapy for phenylketonuria.
Ho G; Reichardt J; Christodoulou J
J Inherit Metab Dis; 2013 Nov; 36(6):955-9. PubMed ID: 23532445
[TBL] [Abstract][Full Text] [Related]
14. Comparison of read-through effects of aminoglycosides and PTC124 on rescuing nonsense mutations of HERG gene associated with long QT syndrome.
Yu H; Liu X; Huang J; Zhang Y; Hu R; Pu J
Int J Mol Med; 2014 Mar; 33(3):729-35. PubMed ID: 24366185
[TBL] [Abstract][Full Text] [Related]
15. Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model.
Brendel C; Belakhov V; Werner H; Wegener E; Gärtner J; Nudelman I; Baasov T; Huppke P
J Mol Med (Berl); 2011 Apr; 89(4):389-98. PubMed ID: 21120444
[TBL] [Abstract][Full Text] [Related]
16. A lack of premature termination codon read-through efficacy of PTC124 (Ataluren) in a diverse array of reporter assays.
McElroy SP; Nomura T; Torrie LS; Warbrick E; Gartner U; Wood G; McLean WH
PLoS Biol; 2013; 11(6):e1001593. PubMed ID: 23824517
[TBL] [Abstract][Full Text] [Related]
17. PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model.
Du M; Liu X; Welch EM; Hirawat S; Peltz SW; Bedwell DM
Proc Natl Acad Sci U S A; 2008 Feb; 105(6):2064-9. PubMed ID: 18272502
[TBL] [Abstract][Full Text] [Related]
18. Strategies against Nonsense: Oxadiazoles as Translational Readthrough-Inducing Drugs (TRIDs).
Campofelice A; Lentini L; Di Leonardo A; Melfi R; Tutone M; Pace A; Pibiri I
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284579
[TBL] [Abstract][Full Text] [Related]
19. Read-through strategies for suppression of nonsense mutations in Duchenne/ Becker muscular dystrophy: aminoglycosides and ataluren (PTC124).
Finkel RS
J Child Neurol; 2010 Sep; 25(9):1158-64. PubMed ID: 20519671
[TBL] [Abstract][Full Text] [Related]
20. The effect of PTC124 on choroideremia fibroblasts and iPSC-derived RPE raises considerations for therapy.
Torriano S; Erkilic N; Baux D; Cereso N; De Luca V; Meunier I; Moosajee M; Roux AF; Hamel CP; Kalatzis V
Sci Rep; 2018 May; 8(1):8234. PubMed ID: 29844446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
